IRIS UniCatt

Napolitano, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 877
NA - Nord America 746
EU - Europa 610
SA - Sud America 301
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.566
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 703
SG - Singapore 417
BR - Brasile 246
CN - Cina 196
IT - Italia 183
VN - Vietnam 93
DE - Germania 86
SE - Svezia 86
FR - Francia 61
GB - Regno Unito 39
FI - Finlandia 37
KR - Corea 28
ID - Indonesia 27
CA - Canada 26
IE - Irlanda 23
IN - India 19
AR - Argentina 18
IQ - Iraq 18
RU - Federazione Russa 16
HK - Hong Kong 15
ZA - Sudafrica 14
ES - Italia 13
PL - Polonia 13
BD - Bangladesh 12
MX - Messico 12
TR - Turchia 11
CO - Colombia 9
EC - Ecuador 9
JP - Giappone 9
AT - Austria 8
NL - Olanda 8
IL - Israele 7
SI - Slovenia 6
UA - Ucraina 6
CH - Svizzera 4
LT - Lituania 4
MA - Marocco 4
PT - Portogallo 4
SA - Arabia Saudita 4
UY - Uruguay 4
VE - Venezuela 4
BO - Bolivia 3
CL - Cile 3
EG - Egitto 3
JO - Giordania 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
JM - Giamaica 2
KE - Kenya 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 2.566
Salva come PNG Salva come JPEG
Città #
Singapore 229
Ashburn 115
Chandler 70
Rome 54
New York 51
Hefei 50
Beijing 48
Los Angeles 43
Ho Chi Minh City 36
The Dalles 35
Munich 31
Seoul 28
Frankfurt am Main 26
São Paulo 23
Hanoi 22
Dublin 21
Jakarta 21
Helsinki 19
Kent 16
Milan 16
Hong Kong 15
Turku 13
Dallas 12
Marseille 12
Montreal 12
North Bergen 12
Boardman 11
Boston 11
Houston 10
Poplar 10
Brooklyn 9
Denver 9
Moscow 9
Belo Horizonte 8
Nuremberg 8
Warsaw 8
Johannesburg 7
Najaf 7
Princeton 7
Tokyo 7
Baghdad 6
Falkenstein 6
Guarulhos 6
Macerata 6
Mexico City 6
Porto Alegre 6
Rio de Janeiro 6
Seattle 6
Stockholm 6
Atlanta 5
Bogotá 5
Cagliari 5
Caxias do Sul 5
Chicago 5
Hyderabad 5
Paris 5
Tel Aviv 5
Toronto 5
Appignano 4
Brasília 4
Bremen 4
Buffalo 4
Can Tho 4
Düsseldorf 4
Lappeenranta 4
Manaus 4
Phoenix 4
Quito 4
Roubaix 4
Salvador 4
Zurich 4
Amman 3
Calgary 3
Cape Town 3
Chelsea 3
Chennai 3
Council Bluffs 3
Da Nang 3
Dhaka 3
Istanbul 3
Joinville 3
Juiz de Fora 3
Lisbon 3
Madrid 3
Montevideo 3
Orem 3
Pune 3
Querétaro 3
San Diego 3
São Carlos 3
São Gonçalo 3
São José 3
São José do Rio Preto 3
Trieste 3
Washington 3
Wroclaw 3
Albano Laziale 2
Ancona 2
Anguillara 2
Antalya 2
Totale 1.385
Salva come PNG Salva come JPEG
Nome #
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 141
The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic 128
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study 128
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 112
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 101
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 98
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 97
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 96
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre 94
Addressing Nutritional Knowledge Gaps in Inflammatory Bowel Disease: A Scoping Review 90
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 90
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 87
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 87
Self-care in patients affected by inflammatory bowel disease and caregiver contribution to self-care (IBD-SELF): a protocol for a longitudinal observational study 87
Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases 85
Validity and Reliability of the Self-Care of Chronic Illness Inventory in Patients Living With Inflammatory Bowel Disease 84
Knowledge of perianal Crohn's disease among nurses in an Italian tertiary centre 80
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 78
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 78
Patient satisfaction with nursing care during biological therapy for inflammatory bowel disease: An observational study 77
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 75
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 72
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 71
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 66
Evaluation of factors associated with trust in telemedicine in patients with inflammatory bowel disease during COVID-19 pandemic: a multicenter cross-sectional survey 60
The inflammatory bowel disease care manager: Italian state of the art 59
The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19 59
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 59
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER Study 55
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus 49
Psychological Assessment and Psychosocial Outcomes in Bariatric Surgery Candidates: A Retrospective Study 40
Exploring the Mediating Role of Self-Efficacy in the Relationship Between Caregiver Contribution and Resilience in Inflammatory Bowel Disease 11
Knowledge of perianal Crohn's disease among nurses in an Italian tertiary centre 4
The role of resilience in mitigating depression and anxiety in patients with inflammatory bowel diseases 3
Totale 2.601
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 1 2
2021/202258 1 0 0 2 1 0 0 3 0 18 16 17
2022/2023222 36 28 10 32 18 14 22 7 18 6 15 16
2023/2024251 6 40 16 19 11 35 21 7 17 21 24 34
2024/2025771 8 11 63 22 41 24 59 24 87 88 178 166
2025/20261.296 251 160 158 308 328 91 0 0 0 0 0 0
Totale 2.601